sharecast

{{ storiesRelated.title }}

Aim Bulletin
30 Jan
dl lexington gold aim north carolina south carolina precious metals gold explorer developer producer logo
Lexington Gold reports drilling progress at Bothaville

Lexington Gold updated the market on its 2023-2024 drilling programme at the Bothaville Project in South Africa’s Witwatersrand Gold Basin on Tuesday.

30 Jan
dl hutchmed china aim pharmaceuticals drug medicine research development logo
Hutchmed's 'Elunate' approved under new Hong Kong rules

Hutchmed China announced the approval of its drug ‘Elunate’, or fruquintinib, by the Pharmacy and Poisons Board of Hong Kong on Tuesday, for the treatment of adult patients with previously treated metastatic colorectal cancer (CRC).

30 Jan
dl gb group plc aim gbg technology software and computer services logo 20230323
GB Group trading as expected as new CEO takes reins

Digital location and identity software specialist GB Group announced on Tuesday that Dev Dhiman had now started as its new chief executive officer, following a successful transition period.

30 Jan
dl renew holdings aim engineering services infrastructure provider logo
Renew Holdings confident in year-end order book

Infrastructure engineering service provider Renew Holdings said in an update on Tuesday that in the first quarter of its new financial year, it maintained the positive trading momentum seen in 2023, aligning with the board's expectations.

30 Jan
dl fintel plc fntl industrials industrial goods and services industrial support services professional business support services aim logo 20230919 1400
Fintel upbeat after year filled with acquisitions

Financial technology and support service specialist Fintel described a resilient full-year performance in a trading update on Tuesday, with results expected to meet its expectations.

30 Jan
dl northcoders group aim technology software and computer services logo
Northcoders ends 2023 in line with revised expectations

Technology training firm Northcoders said in a trading update on Tuesday that its performance in 2023 aligned with revised market forecasts.

30 Jan
dl uniphar plc aim consumer staples personal care drug and grocery stores drug retailers logo 20230228
Uniphar ends year in line with expectations

Pharmaceutical and medical technology service company Uniphar said in an update on Tuesday that its performance in 2023 met its own expectations in terms of gross profit and EBITDA, while also achieving normalised free cash flow conversion in line with medium-term guidance.